C4 Therapeutics Inc. – Underwriting Agreements

NASDAQ: CCCC
Share price (9/30/26): $3.33
Market cap (9/30/26): $410 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Underwriting Agreements Filter

from SCHEDULE 13G/A Underwriting agreement

from SCHEDULE 13G Underwriting agreement

from 8-K 48 pages 21,895,000 Shares of Common Stock Pre-Funded Warrants to Purchase Up to 28,713,500 Shares of Common Stock Class a Warrants to Purchase Up to 50,608,500 Shares of Common Stock (Or Pre-Funded Warrants in Lieu Thereof) Class B Warrants to Purchase Up to 50,608,500 Shares of Common Stock (Or Pre-Funded Warrants in Lieu Thereof) C4 Therapeutics, Inc. Underwriting Agreement

from S-3 42 pages Underwriting agreement

from SC 13G 1 page Joint Filing Agreement

from S-3ASR 40 pages C4 Therapeutics, Inc. Shares of Common Stock Sales Agreement

from S-1 43 pages J.P. Morgan Securities LLC Jefferies LLC Evercore Group L.L.C. as Representatives of the Several Underwriters C/O J.P. Morgan Securities LLC 383 Madison Avenue New York, New York 10179 C/O Jefferies LLC 520 Madison Avenue New York, New York 10022 C/O Evercore Group L.L.C. 55 East 52nd Street New York, New York 10055 Ladies and Gentlemen

from S-1/A 48 pages [●] C4 Therapeutics, Inc. Underwriting Agreement